These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 9531299)

  • 1. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
    Wright A; Morrison SL
    J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
    Wright A; Morrison SL
    J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region.
    Tao MH; Morrison SL
    J Immunol; 1989 Oct; 143(8):2595-601. PubMed ID: 2507634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
    Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
    J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
    Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
    Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycobiology: 'the function of sugar in the IgG molecule'.
    Dwek RA; Lellouch AC; Wormald MR
    J Anat; 1995 Oct; 187 ( Pt 2)(Pt 2):279-92. PubMed ID: 7591992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.
    Smith RI; Coloma MJ; Morrison SL
    J Immunol; 1995 Mar; 154(5):2226-36. PubMed ID: 7868896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid IgA2/IgG1 antibodies with tailor-made effector functions.
    Chintalacharuvu KR; Vuong LU; Loi LA; Larrick JW; Morrison SL
    Clin Immunol; 2001 Oct; 101(1):21-31. PubMed ID: 11580223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure.
    Wright A; Sato Y; Okada T; Chang K; Endo T; Morrison S
    Glycobiology; 2000 Dec; 10(12):1347-55. PubMed ID: 11159927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4.
    Zhou F; Xu W; Hong M; Pan Z; Sinko PJ; Ma J; You G
    Mol Pharmacol; 2005 Mar; 67(3):868-76. PubMed ID: 15576633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human IgG2 variants of chimeric anti-CD3 are nonmitogenic to T cells.
    Cole MS; Anasetti C; Tso JY
    J Immunol; 1997 Oct; 159(7):3613-21. PubMed ID: 9317161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.
    Ferrara C; Brünker P; Suter T; Moser S; Püntener U; Umaña P
    Biotechnol Bioeng; 2006 Apr; 93(5):851-61. PubMed ID: 16435400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life.
    Zuckier LS; Chang CJ; Scharff MD; Morrison SL
    Cancer Res; 1998 Sep; 58(17):3905-8. PubMed ID: 9731501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
    Morgan A; Jones ND; Nesbitt AM; Chaplin L; Bodmer MW; Emtage JS
    Immunology; 1995 Oct; 86(2):319-24. PubMed ID: 7490135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.
    Neumaier M; Shively L; Chen FS; Gaida FJ; Ilgen C; Paxton RJ; Shively JE; Riggs AD
    Cancer Res; 1990 Apr; 50(7):2128-34. PubMed ID: 2107969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
    Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
    J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity.
    Yamane-Ohnuki N; Kinoshita S; Inoue-Urakubo M; Kusunoki M; Iida S; Nakano R; Wakitani M; Niwa R; Sakurada M; Uchida K; Shitara K; Satoh M
    Biotechnol Bioeng; 2004 Sep; 87(5):614-22. PubMed ID: 15352059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.